This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Apr 20;41(12):2296-2297.

doi: 10.1200/JCO.22.02468. Epub 2023 Feb 15.

Reply to O. Devlin et al

Sunandana Chandra¹, Jacob S Choi¹, Jeffrey A Sosman¹

Affiliations

PMID: 36791338
DOI: 10.1200/JCO.22.02468

Comment

Reply to O. Devlin et al

Sunandana Chandra et al. J Clin Oncol. 2023.

. 2023 Apr 20;41(12):2296-2297.

doi: 10.1200/JCO.22.02468. Epub 2023 Feb 15.

Authors

Sunandana Chandra¹, Jacob S Choi¹, Jeffrey A Sosman¹

Affiliation

¹ Sunandana Chandra, MD, MS, Jacob S. Choi, MD, PhD, and Jeffrey A. Sosman, MD, Division of Hematology Oncology, Northwestern University, Chicago, IL.

PMID: 36791338
DOI: 10.1200/JCO.22.02468

No abstract available

PubMed Disclaimer

Comment on

Sequencing of Targeted Treatment and Immunotherapy in Advanced BRAF-Mutant Melanoma.
Devlin O, Oladipo O. Devlin O, et al. J Clin Oncol. 2023 Apr 20;41(12):2295-2296. doi: 10.1200/JCO.22.02250. Epub 2023 Feb 15. J Clin Oncol. 2023. PMID: 36791370 No abstract available.

Publication types

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.